Original language | English |
---|---|
Pages (from-to) | 4093-4094 |
Number of pages | 2 |
Journal | Journal of Clinical Oncology |
Volume | 35 |
Issue number | 36 |
DOIs | |
Publication status | Published - 20 Dec 2017 |
Chemoimmunotherapy may not be dead yet in chronic lymphocytic leukemia, but fludarabine plus cyclophosphamide plus rituximab is potentially facing life support
Research output: Contribution to journal › Letter › Other › peer-review
2
Citations
(Scopus)